Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

Global private equity healthcare specialist ARCHIMED further expands its presence in the Consumer Health sector with the acquisition of Groupe Laboratoire Rivadis.

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

ARCHIMED buys Stragen Pharma, a leader in the development, registration and distribution of hard-to-make generic drugs

 June

 24, 

2021

ARCHIMED’s Fytexia buys B Natural, the European leader in the extraction and refinement of compounds produced by bees

 June

 1, 

2021

ARCHIMED’s Direct Healthcare Group buys United Care BV

 March

 24, 

2021

ARCHIMED’s Direct Healthcare Group acquires Talley

 March

 3, 

2021

Acquisition by ARCHIMED’s NAMSA makes it the preeminent contract research organization for medtech lab testing

 March

 2, 

2021

ARCHIMED strengthens its North American capabilities

 January

 26, 

2021

< 1 … 7 8 9 10 11 … 17 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top